Nothing here constitutes medical advice or a product endorsement
Studies by Kiel, Holst and Deacon uncovered that GLP-1 is rapidly degraded by an enzyme called DPP-4
Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
500 M) (n = 6
A medical examination will help identify possible diseases, such as problems with the pancreas or thyroid gland, which can affect the safety of using the drug
This is the markets clearest fit for them
